Press Release by Industry
- All Industries
- Agriculture
- Automotive
- Banking
- Business Technology
- Construction
- Consumer Goods
- Consumer Technology
- Education
- Energy
- Entertainment & Media
- Environment
- Financial Services
- Food and Beverage
- General Business
- Healthcare
- Hospitality
- Information Technology
- Insurance
- Heavy Industry & Manufacturing
- Media
- Mining
- People & Culture
- Pharmaceuticals
- Policy & Public Interest
- Real Estate
- Retail
- Sports
- Telecommunications
- Transportation
- Travel
- Utilities
Healthcare - Press Releases
- 1085 Press Releases ยท
- RSS
Published on Fri 21 Mar 2025 7:21:06 UTC
Journal of Emergency Nursing also honors emergency nursing legend
Published on Fri 21 Mar 2025 7:21:02 UTC
SAN CLEMENTE, Calif., March 20, 2025 /PRNewswire/ --Angelalign Technology Inc. ("Angelalign Technology" or the "Company") (6699.HK) released its financial results for fiscal year 2024. Driven by rapid expansion in global markets and continued innovation in digital orthodontics, the Company delivered a robust global performance despite complex global market challenges.
Published on Fri 21 Mar 2025 7:21:01 UTC
WASHINGTON, March 20, 2025 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2025 on Tuesday, April 22, 2025 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss its financial performance, as well as future expectations.
Published on Fri 21 Mar 2025 7:20:57 UTC
Comprehensive Analysis Exposes Severe Lung Diseases from Artificial Stone Dust Exposure
Published on Fri 21 Mar 2025 7:20:54 UTC
HIGHLAND PARK, Ill., March 20, 2025 /PRNewswire/ -- The Collaborative Community Housing Initiativeis excited to announce its recent acquisition of a former memory care community in Highland Park, Illinois. This purchase marks a significant step forward in CCHI's mission to create an inclusive living environment for individuals with intellectual and developmental disabilities.
Published on Fri 21 Mar 2025 7:20:51 UTC
Un anlisis exhaustivo expone enfermedades pulmonares graves por la exposicin al polvo de piedra artificial
Published on Fri 21 Mar 2025 7:20:47 UTC
Grant provides Native Veterans access to the Mobilized Native Intensive Clinical Program
Published on Fri 21 Mar 2025 7:20:41 UTC
DARZALEX has significant market potential as a leading monoclonal antibody for multiple myeloma treatment. Its approval in various combinations for both newly diagnosed and relapsed/refractory patients has expanded its reach. The multiple myeloma market is expected to grow steadily, with DARZALEX contributing significantly due to its strong clinical efficacy and growing adoption.
Published on Fri 21 Mar 2025 7:20:36 UTC
VICTORIA, BC, March 20, 2025 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere technology designed to optimize drug delivery for applications with significant unmet need, today announced its financial results for the fourth quarter of 2024. All dollar values are in U.S. dollars unless stated otherwise.
Published on Fri 21 Mar 2025 7:20:33 UTC
A case study on how a leading European dermatology company sought regulatory intelligence support to navigate the CDSCO framework. The company aimed to gain a comprehensive understanding of key guidelines, requirements, and approval processes to file their market-ready product in India successfully.
Published on Fri 21 Mar 2025 7:20:28 UTC
LOS ANGELES, March 20, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections, today announced financial results for its fourth quarter and full-year ended December 31, 2024, and provided a corporate update.
Published on Fri 21 Mar 2025 7:20:24 UTC
SAN FRANCISCO, March 20, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that the company will be webcasting its participation in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference:
Published on Fri 21 Mar 2025 7:20:22 UTC
TREMFYA is the only IL-23i to demonstrate clinical remission and endoscopic response, both at one year, with a fully subcutaneous induction regimen
Published on Fri 21 Mar 2025 7:20:17 UTC
HealthMark Group celebrates another year as a USA Today Top Workplace honoree, which recognizes companies nationwide taking the lead in employee satisfaction
Published on Fri 21 Mar 2025 7:20:14 UTC
EAST HANOVER, N.J., March 20, 2025 /PRNewswire/ -- Novartis today announced that oral Fabhalta (iptacopan) has received U.S. Food and Drug Administration (FDA) approval for the treatment ofadults with C3 glomerulopathy (C3G), to reduce proteinuria, making it the first and only treatment approved for this condition1-4.
Published on Fri 21 Mar 2025 7:20:13 UTC
ALPHARETTA, Ga., March 20, 2025 /PRNewswire/ -- OrthoMinds, LLC ("OrthoMinds") is providing notice of a recent data security event.OrthoMinds is notifying clients and potentially impacted individuals of the event. This notice provides information about the event, OrthoMinds' response, and steps potentially impacted individuals may take. OrthoMinds takes the confidentiality, privacy, and security of information very seriously.
Published on Fri 21 Mar 2025 7:19:49 UTC
LANSING, Mich., March 20, 2025 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) will issue its third-quarter earnings release before the opening of the market on Wednesday, April 9, 2025. Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time, to discuss the financial results.
Published on Fri 21 Mar 2025 7:18:41 UTC
SHANGHAI, March 20, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been recognized by the environmental non-profit CDP for leadership in corporate transparency and performance on water security, securing a place on the organization's annual "A List"for the second year.
Published on Fri 21 Mar 2025 7:18:06 UTC
HONG KONG, March 20, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) presented promising phase III safety run-in results from the COMPASSION-18/AK104-305 study, at the 2025 Annual Meeting of the Society of Gynecologic Oncology (SGO). The study evaluates the global first-in-class PD-1/CTLA-4 bispecific antibody, cadonilimab (AK104), in combination with concurrent chemoradiotherapy (CCRT) for the treatment of locally advanced cervical cancer.
Published on Thu 20 Mar 2025 9:42:22 UTC
HELSINKI, March 20, 2025 /PRNewswire/ -- Finland leads the world in happiness for the eighth year running, with an average score of 7.7 out of 10. As the capital of happiness, Helsinki shows that the core of happiness hasn't changed - it's simply found new ways to thrive and welcomed new people along the way.
Published on Thu 20 Mar 2025 9:42:20 UTC
HELSINKI, March 20, 2025 /PRNewswire/ -- Finland leads the world in happiness for the eighth year running, with an average score of 7.7 out of 10. As the capital of happiness, Helsinki shows that the core of happiness hasn't changed - it's simply found new ways to thrive and welcomed new people along the way.
Published on Thu 20 Mar 2025 9:42:19 UTC
RIYADH, Saudi Arabia, March 20, 2025 /PRNewswire/ -- BristolMyers Squibb, a leading global biopharmaceutical company, has recently appointed Osama Braiwish as its General Manager for Saudi Arabia and Gulf Countries, an affiliate covering Saudi Arabia, United Arab Emirates, Kuwait, Qatar, Oman, Bahrain, and Jordan.
Published on Thu 20 Mar 2025 9:42:14 UTC
FORT LAUDERDALE, Fla., March 20, 2025 /PRNewswire/ -- Discover the groundbreaking work of Starlight Cardiovascular, a company dedicated to creating life-saving technologies for children with congenital heart disease, a condition affecting countless families nationwide.
Published on Thu 20 Mar 2025 9:41:59 UTC
(PRNewsfoto/Transamerica Institute) Global Coalition on Aging
Published on Thu 20 Mar 2025 9:39:58 UTC
BASEL, Switzerland, March 20, 2025 /PRNewswire/ -- Versameb AG ("Versameb"), a clinical stage company focused on transforming RNA therapeutics to treat unmet medical needs, today announced the issuance of the Notice of Allowance of first Composition of Matter patent in China for its innovative signal peptide technology. This achievement represents a significant milestone in Versameb's mission to advance RNA-based therapeutics and expand its intellectual property portfolio globally.
Press Release by Industry
- All Industries
- Agriculture
- Automotive
- Banking
- Business Technology
- Construction
- Consumer Goods
- Consumer Technology
- Education
- Energy
- Entertainment & Media
- Environment
- Financial Services
- Food and Beverage
- General Business
- Healthcare
- Hospitality
- Information Technology
- Insurance
- Heavy Industry & Manufacturing
- Media
- Mining
- People & Culture
- Pharmaceuticals
- Policy & Public Interest
- Real Estate
- Retail
- Sports
- Telecommunications
- Transportation
- Travel
- Utilities